| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d37bf8b7cbbf0139e0a5789e6776a4c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c36bf714efcd64b0e3276a8c0338b7ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b367966c371a94cf64a3ab26985b6ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c665e86b08279b1b3dca8c62f1b0d671
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_546e57874fcf716f81e912c998054992
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e209a43bf4c935b71486ec46ef684857 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2001-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_deb04b04306e37ba9fc7afe9ce7f9740
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfda1e1fbf1cb6b78ff3b34cf1613f0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c69f1fad340800b4fc53d3ba7a6a852
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c8fb8e8af4d30448872784ba118617b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa3e90865e511265bb43455dcedd7e0e |
| publicationDate |
2002-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0224708-A1 |
| titleOfInvention |
Prodrugs of a 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotic |
| abstract |
The present invention relates to prodrugs of the antibiotic compound (7R)-7-[(Z)-2-(2-amino-5-chlorothiazol-4-yl)-2-(hydroxylimino)acetamido]acetamidol]-3-{3-(2-aminoethylthiomethyl]-pyrid-4-ylthio}-3-cephem-4-carbocyllic acid, where the prodrugs are substantially more water soluble at or near neutral pH than the parent compound. |
| priorityDate |
2000-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |